1,2-distearoyllecithin has been researched along with arginyl-glycyl-aspartic acid in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bunker, A; Magarkar, A; Róg, T | 1 |
1 other study(ies) available for 1,2-distearoyllecithin and arginyl-glycyl-aspartic acid
| Article | Year |
|---|---|
A computational study suggests that replacing PEG with PMOZ may increase exposure of hydrophobic targeting moiety.
Topics: Cholesterol; Drug Delivery Systems; Humans; Hydrophobic and Hydrophilic Interactions; Ligands; Liposomes; Molecular Dynamics Simulation; Oligopeptides; Phosphatidylcholines; Polyamines; Polyethylene Glycols; Surface Properties | 2017 |